Analysis of genetic factors associated with fatty liver disease-related hepatocellular carcinoma.

Tomomi KogisoYuri OgasawaraKentaro HoriuchiMakiko TaniaiKatsutoshi Tokushige

Published in: Cancer medicine (2023)

Inhibiting HSD17B13 activity may prevent HCC development, particularly in alcohol-related FLD and low-risk patients. Therefore, combinations of SNPs and other risk factors can be used for screening FLD-HCC.

Keyphrases

risk factors
end stage renal disease
ejection fraction
genome wide
prognostic factors
peritoneal dialysis
signaling pathway
copy number
patient reported outcomes
fatty acid
patient reported